Gobis Katarzyna, Foks Henryk, Sławiński Jarosłw, Augustynowicz-Kopeć Ewa, Napiórkowska Agnieszka
Department of Organic Chemistry, Medical University of Gdańsk, Gdańsk, Poland.
Department of Microbiology, Institute of Tuberculosis and Pulmonary Diseases, Warsaw, Poland.
Monatsh Chem. 2013;144(8):1197-1203. doi: 10.1007/s00706-013-0988-5. Epub 2013 May 14.
A series of novel 1,2,4-thiadiazine 1,1-dioxides were synthesized by condensation of 2-chlorobenzenesulfonamide and 4-chloropyridine-3-sulfonamide with heterocyclic methyl carbimidates obtained from heterocyclic carbonitriles and used at the time of their creation. Substituted amidines were isolated as the intermediates in the reaction with 2-chlorobenzenesulfonamide. Those intermediates were successfully cyclized to corresponding 1,2,4-thiadiazine 1,1-dioxides in pyridine with the addition of DBU. The newly synthesized compounds were evaluated for their tuberculostatic and anticancer activities. Eight compounds were able to inhibit the growth of some renal and non-small cell lung cancer cell lines.
通过2-氯苯磺酰胺和4-氯吡啶-3-磺酰胺与由杂环腈制得的杂环甲基氨基甲酰亚胺缩合反应,合成了一系列新型的1,2,4-噻二嗪1,1-二氧化物,并在合成时使用。在与2-氯苯磺酰胺的反应中,分离得到取代脒作为中间体。在吡啶中加入DBU,这些中间体成功环化生成相应的1,2,4-噻二嗪1,1-二氧化物。对新合成的化合物进行了抑菌和抗癌活性评估。八种化合物能够抑制某些肾癌细胞系和非小细胞肺癌细胞系的生长。